STAA - STAAR Surgical Company

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
142,488
123,954
90,611
82,432
77,123
Cost of Revenue
36,366
32,444
26,331
24,063
24,400
Gross Profit
106,122
91,510
64,280
58,369
52,723
Operating Expenses
Research Development
23,594
22,028
19,116
20,294
14,761
Selling General and Administrative
71,831
62,887
48,795
50,730
43,299
Total Operating Expenses
95,425
84,915
67,911
71,024
58,060
Operating Income or Loss
10,697
6,595
-3,631
-12,655
-5,337
Interest Expense
-
-
112
115
128
Total Other Income/Expenses Net
-359
-121
1,447
323
-190
Income Before Tax
11,364
6,639
-2,296
-12,444
-5,605
Income Tax Expense
2,599
1,671
-157
-315
928
Income from Continuing Operations
8,765
4,968
-2,139
-12,129
-6,533
Net Income
8,765
4,968
-2,139
-12,129
-6,533
Net Income available to common shareholders
8,765
4,968
-2,139
-12,129
-6,533
Reported EPS
Basic
-
0.12
-0.05
-0.30
-0.17
Diluted
-
0.11
-0.05
-0.30
-0.17
Weighted average shares outstanding
Basic
-
42,587
41,004
40,329
39,260
Diluted
-
45,257
41,004
40,329
39,260
EBITDA
-
9,059
-277
-9,437
-3,076